an increasing trendp > 0.05
In addition, the aspirin group exhibited a significantly reduced 6-keto-PGF 1α content (control: 3602.68 ± 1479.11 pg/mL, aspirin: 353.53 ± 153.57 pg/mL, p < 0.05), while the low- (1964.19 ± 1102.13 pg/mL), medium- (4169.17 ± 2011.74 pg/mL), and high-dose DAS groups (6032.05 ± 4738.57 pg/mL) showed an increasing trend but did not differ from the control (r = 0.352, p > 0.05, Figure 2(b) ).